-
EP0771324
European procedure
Extract from the Register of European Patents
EP About this file: EP0771324
| EP0771324 - CONCENTRATE OF FIBRINOGENE OBTAINED FROM BLOOD PLASMA, PROCESS AND PLANT FOR ITS PREPARATION [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 07.01.2011 Database last updated on 20.07.2024 | Most recent event Tooltip | 07.01.2011 | Patent maintained (B2 publication) | published on 09.02.2011 [2011/06] | Applicant(s) | For all designated states CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Avenue de Tyras, 109 1120 Brussels / BE | [2011/06] |
| Former [1999/39] | For all designated states CAF-DCF Département Central de Fractionnement de la Croix Rouge S.C.R.L. Avenue de Tyras, 109 1120 Brussels / BE | ||
| Former [1997/19] | For all designated states CROIX ROUGE DE BELGIQUE Département Central de Fractionnement, Rue Joseph Stallaert, 5 B-1060 Bruxelles / BE | Inventor(s) | 01 /
LAUB, Ruth 6, avenue Besme 1190 Bruxelles / BE | 02 /
DE WAEL, Luc Herentalsebaan 65 2520 Ranst / BE | [1997/19] | Representative(s) | De Clercq, Ann G. Y., et al De Clercq & Partners cvba Edgard Gevaertdreef 10 a 9830 Sint-Martens-Latem / BE | [2011/06] |
| Former [2006/03] | De Clercq, Ann G. Y., et al De Clercq, Brants & Partners, Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem / BE | ||
| Former [1997/31] | Van Malderen, Michel, et al Office van Malderen Place Reine Fabiola 6/1 1083 Bruxelles / BE | ||
| Former [1997/19] | Van Malderen, Michel, et al Office Van Malderen Place Reine Fabiola 6/1 1083 Bruxelles / BE | Application number, filing date | 95927599.1 | 14.07.1995 | [1997/19] | WO1995BE00069 | Priority number, date | EP19940870121 | 14.07.1994 Original published format: EP 94870121 | [1997/19] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO9602571 | Date: | 01.02.1996 | Language: | FR | [1996/06] | Type: | A1 Application with search report | No.: | EP0771324 | Date: | 07.05.1997 | Language: | FR | The application published by WIPO in one of the EPO official languages on 01.02.1996 takes the place of the publication of the European patent application. | [1997/19] | Type: | B1 Patent specification | No.: | EP0771324 | Date: | 22.09.1999 | Language: | FR | [1999/38] | Type: | B2 New European patent specification | No.: | EP0771324 | Date: | 09.02.2011 | Language: | FR | [2011/06] | Search report(s) | International search report - published on: | EP | 01.02.1996 | Classification | IPC: | C07K14/75, A61L2/18, A61K38/36 | [1997/19] | CPC: |
A61L2/0088 (EP,US);
A61L2/18 (EP,US);
A61L26/0042 (EP,US);
A61P17/02 (EP);
A61P43/00 (EP);
A61P7/04 (EP);
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, IT, LI, NL, SE [1997/19] | Title | German: | FIBRINOGENKONZENTRATE AUS BLUTPLASMA, VERFAHREN UND ANLAGE FÜR IHRE HERSTELLUNG | [1997/19] | English: | CONCENTRATE OF FIBRINOGENE OBTAINED FROM BLOOD PLASMA, PROCESS AND PLANT FOR ITS PREPARATION | [1997/19] | French: | CONCENTRE DE FIBRINOGENE ISSU DE PLASMA SANGUIN, PROCEDE ET INSTALLATION POUR SA PREPARATION | [1997/19] | Entry into regional phase | 22.01.1997 | National basic fee paid | 22.01.1997 | Designation fee(s) paid | 07.11.1996 | Examination fee paid | Examination procedure | 30.01.1996 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 27.01.1997 | Examination requested [1997/19] | 02.06.1998 | Despatch of communication of intention to grant (Approval: No) | 16.09.1998 | Despatch of communication of intention to grant (Approval: later approval) | 03.12.1998 | Communication of intention to grant the patent | 15.12.1998 | Fee for grant paid | 15.12.1998 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
21.06.2000
07.07.2000
ADMISSIBLE Baxter Healthcare Corpn One Baxter Parkway Deerfield, Illinois 60015 / US Opponent's representative Probert, Gareth David Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
| Former [2008/08] | |||
| Opponent(s) | 01
21.06.2000
07.07.2000
ADMISSIBLE Baxter Healthcare Corpn One Baxter Parkway Deerfield, Illinois 60015 / US Opponent's representative Probert, Gareth David Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | ||
| Former [2000/33] | |||
| Opponent(s) | 01
21.06.2000
Baxter Healthcare Corpn One Baxter Parkway Deerfield, Illinois 60015 / US Opponent's representative Dee, Ian Mark Eric Potter Clarkson, Park View House, 58 The Ropewalk Nottingham NG1 5DD / GB | 28.07.2000 | Invitation to proprietor to file observations on the notice of opposition | 25.05.2001 | Reply of patent proprietor to notice(s) of opposition | 14.03.2003 | Despatch of a communication from the opposition division (Time limit: M08) | 06.11.2003 | Reply to a communication from the opposition division | 10.07.2006 | Date of oral proceedings | 24.07.2006 | Despatch of minutes of oral proceedings | 06.08.2009 | Despatch of a communication from the opposition division (Time limit: M07) | 03.02.2010 | Reply to a communication from the opposition division | 15.06.2010 | Despatch of interlocutory decision in opposition | 25.06.2010 | Legal effect of interlocutory decision in opposition | 11.10.2010 | Despatch of communication that the patent will be maintained as amended | 22.12.2010 | Fee for printing new specification paid | Appeal following opposition | 29.09.2006 | Appeal received No. T1528/06 | 21.11.2006 | Statement of grounds filed | 16.05.2008 | Result of appeal procedure: maintenance in amended form | 16.05.2008 | Date of oral proceedings | 06.06.2008 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 10.07.1997 | Renewal fee patent year 03 | 16.06.1998 | Renewal fee patent year 04 | 13.07.1999 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SE | 22.09.1999 | DK | 22.12.1999 | [2003/45] |
| Former [2002/23] | SE | 22.09.1999 | Cited in | International search | [DX]DE3001435 (MEITO SANGYO KK, et al); | [X]EP0018561 (BEHRINGWERKE AG [DE]); | [DA]EP0131740 (NEW YORK BLOOD CENTER INC [US]); | [DX]WO8605190 (CENTRAL BLOOD LAB AUTHORITY [GB]); | [DX]EP0311950 (BIOTEST PHARMA GMBH [DE]); | [DX]WO8912065 (CENTRE REGIONAL DE TRANSFUSION [FR]); | [A]WO9305067 (BAXTER INT [US]); | [A]EP0555135 (AQUITAINE DEV TRANSF SANGUINE [FR]) | Opposition | US4295855 | EP0099445 | EP0378208 | US5099003 | US5252709 |